Pure Biologics SA engages in the research and development of biological drug and non-systemic therapies. It focuses on immuno-oncology, autoimmunology, and rare neurological diseases. The company was founded by Filip Jan Jelen, Maciej Piotr Mazurek, Piotr Jan Jakimowicz, Jacek Józef Otlewski, and Andrzej Jan Trznade and in 2010 and is headquartered in Wroclaw, Poland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company